Profile | GDS5420 / 226088_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1146.02 | 81 |
GSM1296119 | B_lesional_pre-dose | 371.51 | 63 |
GSM1296076 | C_lesional_pre-dose | 310.75 | 61 |
GSM1296092 | D_lesional_pre-dose | 621.36 | 71 |
GSM1296103 | E_lesional_pre-dose | 962.45 | 78 |
GSM1296078 | F_lesional_pre-dose | 327.37 | 62 |
GSM1296107 | G_lesional_pre-dose | 588.41 | 71 |
GSM1296109 | H_lesional_pre-dose | 754.89 | 75 |
GSM1296080 | I_lesional_pre-dose | 692.39 | 73 |
GSM1296090 | J_lesional_pre-dose | 447.07 | 66 |
GSM1296074 | K_lesional_pre-dose | 319.47 | 62 |
GSM1296111 | L_lesional_pre-dose | 307.37 | 59 |
GSM1296099 | M_lesional_pre-dose | 756.28 | 74 |
GSM1296086 | O_lesional_pre-dose | 441.68 | 66 |
GSM1296117 | P_lesional_pre-dose | 596.53 | 71 |
GSM1296113 | Q_lesional_pre-dose | 431.33 | 65 |
GSM1296096 | R_lesional_pre-dose | 813.1 | 76 |
GSM1296105 | S_lesional_pre-dose | 457.16 | 66 |
GSM1296098 | T_lesional_pre-dose | 945.17 | 78 |
GSM1296101 | U_lesional_pre-dose | 932.7 | 78 |
GSM1296121 | V_lesional_pre-dose | 422.58 | 65 |
GSM1296088 | W_lesional_pre-dose | 800.84 | 75 |
GSM1296082 | X_lesional_pre-dose | 521.97 | 69 |
GSM1296115 | Y_lesional_pre-dose | 519.51 | 68 |
GSM1296084 | Z_lesional_pre-dose | 558.78 | 70 |
GSM1296072 | B_lesional_day8 | 319.9 | 60 |
GSM1296069 | L_lesional_day8 | 204.83 | 51 |
GSM1296071 | P_lesional_day8 | 411.24 | 64 |
GSM1296070 | Y_lesional_day8 | 289.16 | 57 |
GSM1296073 | V_lesional_day8 | 307.8 | 60 |
GSM1296034 | A_lesional_day15 | 430.66 | 64 |
GSM1296041 | G_lesional_day15 | 350.99 | 62 |
GSM1296035 | R_lesional_day15 | 909.62 | 77 |
GSM1296038 | U_lesional_day15 | 742.58 | 74 |
GSM1296047 | B_lesional_day15 | 242.25 | 55 |
GSM1296039 | E_lesional_day15 | 587.49 | 71 |
GSM1296042 | H_lesional_day15 | 381.95 | 63 |
GSM1296043 | L_lesional_day15 | 439.84 | 65 |
GSM1296037 | M_lesional_day15 | 468.72 | 66 |
GSM1296046 | P_lesional_day15 | 206.23 | 51 |
GSM1296044 | Q_lesional_day15 | 317.57 | 59 |
GSM1296045 | Y_lesional_day15 | 370.38 | 62 |
GSM1296025 | C_lesional_day15 | 133.71 | 46 |
GSM1296033 | D_lesional_day15 | 652.23 | 72 |
GSM1296027 | I_lesional_day15 | 337.56 | 62 |
GSM1296032 | J_lesional_day15 | 290.38 | 58 |
GSM1296024 | K_lesional_day15 | 181.75 | 52 |
GSM1296031 | W_lesional_day15 | 338.97 | 60 |
GSM1296028 | X_lesional_day15 | 398.67 | 64 |
GSM1296029 | Z_lesional_day15 | 404.4 | 64 |
GSM1296026 | F_lesional_day15 | 349.02 | 62 |
GSM1296030 | O_lesional_day15 | 573.95 | 70 |
GSM1296040 | S_lesional_day15 | 871.56 | 77 |
GSM1296036 | T_lesional_day15 | 680.63 | 72 |
GSM1296048 | V_lesional_day15 | 428.58 | 65 |
GSM1296059 | A_lesional_day43 | 805.71 | 75 |
GSM1296066 | G_lesional_day43 | 374.17 | 62 |
GSM1296060 | R_lesional_day43 | 748.49 | 74 |
GSM1296063 | U_lesional_day43 | 370.99 | 63 |
GSM1296064 | E_lesional_day43 | 357.26 | 63 |
GSM1296067 | H_lesional_day43 | 273.63 | 56 |
GSM1296062 | M_lesional_day43 | 716.52 | 73 |
GSM1296068 | Q_lesional_day43 | 193.87 | 49 |
GSM1296050 | C_lesional_day43 | 121.86 | 44 |
GSM1296057 | D_lesional_day43 | 467.09 | 66 |
GSM1296052 | I_lesional_day43 | 336.88 | 62 |
GSM1296054 | J_lesional_day43 | 282.22 | 57 |
GSM1296049 | K_lesional_day43 | 157.52 | 49 |
GSM1296055 | W_lesional_day43 | 427.75 | 65 |
GSM1296053 | X_lesional_day43 | 367.15 | 62 |
GSM1296058 | Z_lesional_day43 | 482.52 | 67 |
GSM1296051 | F_lesional_day43 | 242.49 | 57 |
GSM1296056 | O_lesional_day43 | 589.82 | 71 |
GSM1296065 | S_lesional_day43 | 493.58 | 67 |
GSM1296061 | T_lesional_day43 | 677.24 | 72 |
GSM1296095 | A_non-lesional_pre-dose | 600.06 | 71 |
GSM1296120 | B_non-lesional_pre-dose | 380.96 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 245.74 | 56 |
GSM1296093 | D_non-lesional_pre-dose | 392.09 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 259.69 | 57 |
GSM1296079 | F_non-lesional_pre-dose | 207.4 | 54 |
GSM1296108 | G_non-lesional_pre-dose | 362.83 | 62 |
GSM1296110 | H_non-lesional_pre-dose | 272.84 | 56 |
GSM1296081 | I_non-lesional_pre-dose | 157.43 | 50 |
GSM1296091 | J_non-lesional_pre-dose | 495.19 | 68 |
GSM1296075 | K_non-lesional_pre-dose | 192.2 | 53 |
GSM1296112 | L_non-lesional_pre-dose | 274.12 | 56 |
GSM1296100 | M_non-lesional_pre-dose | 432.64 | 65 |
GSM1296087 | O_non-lesional_pre-dose | 399.91 | 65 |
GSM1296118 | P_non-lesional_pre-dose | 179.87 | 49 |
GSM1296114 | Q_non-lesional_pre-dose | 214.52 | 52 |
GSM1296097 | R_non-lesional_pre-dose | 532.54 | 69 |
GSM1296106 | S_non-lesional_pre-dose | 394.66 | 63 |
GSM1296102 | U_non-lesional_pre-dose | 461.75 | 65 |
GSM1296122 | V_non-lesional_pre-dose | 224.4 | 53 |
GSM1296089 | W_non-lesional_pre-dose | 317.28 | 59 |
GSM1296083 | X_non-lesional_pre-dose | 377.97 | 63 |
GSM1296116 | Y_non-lesional_pre-dose | 246.85 | 54 |
GSM1296085 | Z_non-lesional_pre-dose | 353.8 | 62 |